Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients.
Mozas P, Sorigué M, Rivas-Delgado A, Rivero A, Correa JG, Castillo C, Nadeu F, Bataller A, Giné E, Baumann T, Delgado J, Villamor N, Campo E, Magnano L, Sancho JM, López-Guillermo A. Mozas P, et al. Eur J Haematol. 2021 Mar;106(3):428-432. doi: 10.1111/ejh.13556. Epub 2020 Dec 14. Eur J Haematol. 2021. PMID: 33247499 No abstract available.
A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma.
Mozas P, Rivero A, Rivas-Delgado A, Nadeu F, Clot G, Correa JG, Castillo C, Bataller A, Baumann T, Giné E, Delgado J, Villamor N, Campo E, Pérez-Galán P, Magnano L, López-Guillermo A. Mozas P, et al. Leuk Lymphoma. 2021 Jan;62(1):104-111. doi: 10.1080/10428194.2020.1821010. Epub 2020 Sep 19. Leuk Lymphoma. 2021. PMID: 32954916
Increased collection efficiency of CD34+ cells after mobilization with preemptive use of plerixafor followed by leukocytapheresis on the same day.
Cid J, Castillo C, Marín P, Carbassé G, Herrera D, Monfort N, Fernández-Avilés F, Gutiérrez-García G, Martínez C, Rosiñol L, Suárez-Lledó M, Rovira M, Urbano-Ispizua Á, Lozano M. Cid J, et al. Transfusion. 2020 Apr;60(4):779-785. doi: 10.1111/trf.15711. Epub 2020 Feb 17. Transfusion. 2020. PMID: 32064638
Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH).
Cid J, Monsalvo S, Castillo C, Pascual C, Moreno-Jiménez G, López-Parra M, Andón C, Guerra L, Esquirol A, Sánchez-Ortega I, Ortega S, Zalba S, Martínez C, Rovira M, Marín P, Lozano M; Grupo Español de Trasplante Hematopoyético (GETH).. Cid J, et al. Transfus Apher Sci. 2021 Apr;60(2):103052. doi: 10.1016/j.transci.2021.103052. Epub 2021 Jan 12. Transfus Apher Sci. 2021. PMID: 33483284
International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Responses.
Cardigan R, New HV, Estcourt L, Zhiburt E, Dubey R, Bengtsson J, Jöud M, Castillo C, Cid J, Lozano M, Gounder D, Flanagan P, Morley S, Clarke G, Devine D, Hindawi S, AlOtaibi A, Bub CB, Kutner JM, Ikeda T, Goto N, Okazaki H, Fontaine MJ, Pasion J, Song L, Latham T, Kerkhoffs JL, de Haas M, Zwaginga JJ, Gathof BS, Ommer K, Pirenne F, Raba M, Francois A, Daly J, Powley T, Dunbar N. Cardigan R, et al. Vox Sang. 2022 Jan;117(1):e1-e20. doi: 10.1111/vox.13130. Epub 2021 Jul 14. Vox Sang. 2022. PMID: 34258774 No abstract available.
31 results